Previous 10 | Next 10 |
SAN FRANCISCO , April 15, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc. (NASDAQ: ZGNX) to the firm's investigation of possible Federal securities law violations. If you purchased or otherwise acquired Zogenix securities between January...
SAN DIEGO , April 13, 2019 /PRNewswire/ -- Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq. , is investigating potential claims against Zogenix, Inc. ("Zogenix") (NASDAQ: ZGNX) for violations of federal...
In business and in particular drug development, rarely do things go as planned. Zogenix ( ZGNX ) is a pharmaceutical company developing therapies for people living with serious and life-threatening rare central nervous system (CNS') conditions. Zogenix's lead product candidate Fintepla is low-...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Zogenix, Inc. investors (“Zogenix” or the “Company”) (NASDAQ: ZGNX ) concerning the Company and its officers’ possible violations of federal securities ...
BOSTON, April 10, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, is investigating whether Zogenix, Inc. (“Zogenix” or the “Company”) (NASDAQ: ZGNX) and certain of its office...
Gainers: ATA (NASDAQ: ATAI ) +97% . Provention Bio (NASDAQ: PRVB ) +29% . PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +24% . Chimerix (NASDAQ: CMRX ) +22% . FARO Technologies (NASDAQ: FARO ) +17% . Soliton (NASDAQ: SOLY ) +15% . GEE Group (NYSEMKT: JOB ) +14% . Geron (NASDAQ: GERN ) ...
Vaxart (NASDAQ: VXRT ) -37% on pricing stock offering. More news on: Vaxart, Inc., Zogenix, Inc., Zosano Pharma Corporation, Stocks on the move, Read more ...
Ionis Pharmaceuticals (NASDAQ: IONS ) initiated with Neutral rating at Cantor Fitzgerald citing Spinraza headwinds. More news on: Ionis Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc., Geron Corporation, Healthcare stocks news, Stocks on the move, , Read more ...
Gainers: PHAS +31.6% . GWPH +4.1% . RUHN +2.9% . IGC +1.9% . SENS +1.9% . More news on: PhaseBio Pharmaceuticals, Inc., GW Pharmaceuticals plc, Hangzhou Ruhnn Holding Co.,Ltd, Stocks on the move, Read more ...
The FDA has issued a Refusal to File (RTF) letter to Zogenix (NASDAQ: ZGNX ) related to its marketing application seeking approval for FINTEPLA (fenfluramine hydrochloride) for the treatment of seizures associated with a rare and severe form of epilepsy called Dravet syndrome. More news ...
News, Short Squeeze, Breakout and More Instantly...
UCB Completes Acquisition of Zogenix, Inc. - Broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy - Total transaction value of up to approximately US$ 1.9 billion / € 1.7 billion. Th...
Zogenix Inc. (NASDAQ:ZGNX) traded today at a new 52-week high of $26.66. Approximately 1.2 million shares have changed hands today, as compared to an average 30-day volume of 3.7 million shares. Zogenix Inc. (NASDAQ:ZGNX) defies analysts with a current price ($26.57) 0.4% above its avera...
Two podium and one poster presentation share important new findings on FINTEPLA’s safety profile and its impact on non-seizure related benefits for LGS patients LGS is a debilitating childhood-onset developmental and epileptic encephalopathy estimated to affect approx...